All entries on Eli Lilly across all areas, newest first. tag:eurotrack.ai,2026:en:en/companies/eli-lilly 2026-03-31T06:00:00Z Eurotrack tag:eurotrack.ai,2026:5f4415f1:en 2026-03-31T06:00:00Z

Eli Lilly is buying Centessa Pharmaceuticals, a developer of treatments for sleep-wake disorders, for US$38 per share in cash plus a contingent value right of up to US$9, up to US$7.8bn in total (Pharmaceutical Executive, 31 March 2026). Update (24 June 2026): the acquisition has been completed (SEC filing via edgar.tools, 24 June 2026). — Sources: https://www.pharmexec.com/view/eli-lilly-enters-7-billion-agreement-acquire-centessa-pharmaceuticals-advance-sleep-wake-treatments · https://app.edgar.tools/news/1d4c5a6fe477a225

tag:eurotrack.ai,2026:046f7e5c:en 2025-08-10T06:00:00Z

US pharmaceutical company Eli Lilly is building a new €2.3 bn production facility in Alzey for diabetes and obesity medications (incl. Mounjaro), operational from late 2027. In June 2026 Lilly announced it would halve the investment to around €1.15 bn over Germany's planned health-insurance reform — creating only about 500 jobs instead of 1,000. — Source: https://www.process.vogel.de/eli-lilly-investition-neue-produktionsstaette-alzey-a-04a6fa156daa6a4384c3e0ff308318bf/